Delivery Order SPE2DR25D3202-SPE2DR26F8E4X
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for $72,275.29 to supply Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by December 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger DLA Troop Support Medical Indefinite Delivery Contract (IDC),...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,196.54 by the Defense Logistics Agency on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,760.26 on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitive award was made by the Defense Logistics Agency, a subordinate agency of the Department of Defense responsible for supplying medical and pharmaceutical products to military healthcare systems. The contract utilizes firm fixed pricing and is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $61,117.01 by the Defense Logistics Agency on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for January 13, 2026. This delivery order is executed under...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $3,433.78 from the Defense Logistics Agency (DLA) on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be completed at the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $15,222.77 and an ultimate completion date of November 5, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $38,297.64 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania headquarters. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E4XDelivery Order
Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was awarded a delivery order valued at $12,175.92 on January 12, 2026, by the Defense Logistics Agency for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by January 13, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare systems globally. Amerisourcebergen's role as a pharmaceutical distributor positions it to supply critical cardiovascular medications to federal medical customers, including military treatment facilities and the Defense Health Agency. This delivery order for Repatha, a cholesterol-management injectable, aligns with the contractor's extensive portfolio of specialty pharmaceutical deliveries across multiple therapeutic domains. The firm's status as a competitively-awarded prime vendor reflects its established capability to meet federal medical procurement requirements, and this task order exemplifies the efficient fulfillment of routine pharmaceutical supply needs through the established DLA medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 1/11/26 |